Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 3
1986 6
1987 22
1988 10
1989 22
1990 20
1991 21
1992 16
1993 24
1994 15
1995 25
1996 19
1997 33
1998 31
1999 25
2000 19
2001 28
2002 16
2003 14
2004 8
2005 12
2006 7
2007 3
2008 4
2009 2
2010 2
2011 4
2012 1
2013 1
2015 1
2016 2
2017 2
2020 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Results by year

Filters applied: . Clear all
Page 1
Gallbladder and cisapride.
Patankar R, Johnson CD. Patankar R, et al. Dig Dis Sci. 1993 Aug;38(8):1562-3. doi: 10.1007/BF01308623. Dig Dis Sci. 1993. PMID: 8344118 Clinical Trial. No abstract available.
Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial.
Mearin F, Rodrigo L, Pérez-Mota A, Balboa A, Jiménez I, Sebastián JJ, Patón C. Mearin F, et al. Clin Gastroenterol Hepatol. 2004 Apr;2(4):301-8. doi: 10.1016/s1542-3565(04)00059-x. Clin Gastroenterol Hepatol. 2004. PMID: 15067624 Clinical Trial.
Medication-related adverse effects were present in 13 of 69 patients (18.8%) in the levosulpiride group and 8 of 71 patients (11.3%) in the cisapride group. Significantly more (P = 0.03) patients treated with cisapride had to abandon the trial because of side effect …
Medication-related adverse effects were present in 13 of 69 patients (18.8%) in the levosulpiride group and 8 of 71 patients (11.3%) in the …
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
Holtmann G, Gschossmann J, Mayr P, Talley NJ. Holtmann G, et al. Aliment Pharmacol Ther. 2002 Sep;16(9):1641-8. doi: 10.1046/j.1365-2036.2002.01322.x. Aliment Pharmacol Ther. 2002. PMID: 12197843 Clinical Trial.
AIM: To compare the efficacy of simethicone with placebo and the prokinetic cisapride in patients with functional dyspepsia. METHODS: One hundred and eighty-five patients with functional dyspepsia were randomized and treated in a double-dummy technique with simethicone (10 …
AIM: To compare the efficacy of simethicone with placebo and the prokinetic cisapride in patients with functional dyspepsia. METHODS: …
Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Hansen JM, et al. Am J Gastroenterol. 1998 Mar;93(3):368-74. doi: 10.1111/j.1572-0241.1998.00368.x. Am J Gastroenterol. 1998. PMID: 9517642 Clinical Trial.
A total of 330 patients with either minor or no abnormalities at endoscopy were randomized to double blind treatment with cisapride 10 mg t.i.d., nizatidine 300 mg at night, or placebo for 2 wk. RESULTS: A symptomatic response was found in 62% of patients on cisapride …
A total of 330 patients with either minor or no abnormalities at endoscopy were randomized to double blind treatment with cisapride 1 …
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
Zix JA, Geerdes-Fenge HF, Rau M, Vöckler J, Borner K, Koeppe P, Lode H. Zix JA, et al. Antimicrob Agents Chemother. 1997 Aug;41(8):1668-72. doi: 10.1128/AAC.41.8.1668. Antimicrob Agents Chemother. 1997. PMID: 9257738 Free PMC article. Clinical Trial.
In a random order, concomitant doses of 10 mg of cisapride three times daily from day -2 to day 2 and 1 g of sucralfate four times daily from day -2 to day 0 were administered. ...The QTc interval for patients receiving sparfloxacin and cisapride was prolonged by 7. …
In a random order, concomitant doses of 10 mg of cisapride three times daily from day -2 to day 2 and 1 g of sucralfate four times da …
Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
Sabbatini F, Minieri M, Manzi G, Piai G, D'Angelo V, Mazzacca G. Sabbatini F, et al. Ital J Gastroenterol. 1991 Jan;23(1):1-4. Ital J Gastroenterol. 1991. PMID: 1747493 Clinical Trial.
Mild adverse reactions were reported in 6 out of 23 cisapride-treated patients and in 10 out of 20 clebopride-treated patients who completed the study. The most common side effect of cisapride was diarrhoea and that of clebopride was drowsiness. Cisapride app …
Mild adverse reactions were reported in 6 out of 23 cisapride-treated patients and in 10 out of 20 clebopride-treated patients who co …
Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride.
Champion MC. Champion MC. Scand J Gastroenterol Suppl. 1989;165:44-52; discussion 52-3. doi: 10.3109/00365528909091230. Scand J Gastroenterol Suppl. 1989. PMID: 2690324 Review.
There have been several long term studies (greater than 4 weeks) of cisapride in a variety of gastroparetic conditions. All of these studies have used cisapride 10 mg t.i.d. or q.i.d. ...Combined studies In two combined studies, cisapride has been shown to be …
There have been several long term studies (greater than 4 weeks) of cisapride in a variety of gastroparetic conditions. All of these …
Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial.
Arvanitakis C, Nikopoułos A, Theoharidis A, Giannoulis E, Vagios I, Anthopoulou H, Michailidis D, Tourkantonis A. Arvanitakis C, et al. Aliment Pharmacol Ther. 1993 Dec;7(6):635-41. doi: 10.1111/j.1365-2036.1993.tb00145.x. Aliment Pharmacol Ther. 1993. PMID: 8161670 Clinical Trial.
The evaluable cohort included 37 patients who completed the trial, 18 in the cisapride group and 19 in the ranitidine group. Three patients were withdrawn from the trial; one on ranitidine developed severe anaphylactic reaction, one on cisapride severe dizziness and …
The evaluable cohort included 37 patients who completed the trial, 18 in the cisapride group and 19 in the ranitidine group. Three pa …
A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
Rösch W, Vinson B, Sassin I. Rösch W, et al. Z Gastroenterol. 2002 Jun;40(6):401-8. doi: 10.1055/s-2002-32130. Z Gastroenterol. 2002. PMID: 12055663 Clinical Trial.
AIM: To compare the efficacy of the herbal preparation STW 5 (Iberogast ((R))) and the research preparation STW 5-II with cisapride for treatment of patients with dysmotility type of functional dyspepsia. PATIENTS AND METHODS: After a diagnostic work-up and 7 days wash-out …
AIM: To compare the efficacy of the herbal preparation STW 5 (Iberogast ((R))) and the research preparation STW 5-II with cisapride f …
The influence of esomeprazole and cisapride on gastroesophageal reflux during anesthesia in dogs.
Zacuto AC, Marks SL, Osborn J, Douthitt KL, Hollingshead KL, Hayashi K, Kapatkin AS, Pypendop BH, Belafsky PC. Zacuto AC, et al. J Vet Intern Med. 2012 May-Jun;26(3):518-25. doi: 10.1111/j.1939-1676.2012.00929.x. Epub 2012 Apr 10. J Vet Intern Med. 2012. PMID: 22489656 Free article. Clinical Trial.
OBJECTIVE: To determine whether preanesthetic IV administration of esomeprazole alone or esomeprazole and cisapride increases esophageal pH and decreases the frequency of GER in anesthetized dogs using combined multichannel impedance and pH monitoring. ...RESULTS: Eight of …
OBJECTIVE: To determine whether preanesthetic IV administration of esomeprazole alone or esomeprazole and cisapride increases esophag …
418 results